Although FASN is important for the modulation of cell death in ovarian cancer cells by engaging in a caspase-2 regulatory mechanism [33], high FASN expression was not found to predict poor OS and DFS in ovarian serous cystadenocarcinoma. The gene discussed is FASN; the disease is ovarian serous cystadenocarcinoma.